Patients with cirrhosis (n=1034) | Patients without cirrhosis (n=991) | ||
---|---|---|---|
Esophageal variceal bleeding (n=555) | Non-variceal bleeding (N=479) | ||
Age—years (SD) | 50 (9) | 52 (10) | 53 (15) |
Gender—female (%) | 125 (23) | 163 (34) | 351 (35) |
Ethnicity | |||
Hispanic | 305 (55%) | 212 (44%) | 329 (33%) |
White | 164 (30%) | 170 (36%) | 261 (27%) |
African-American | 67 (12%) | 85 (18%) | 369 (37%) |
Other | 19 (3%) | 12 (2%) | 32 (3%) |
In-hospital mortality | 40 (7.0%) | 29 (7.0%) | 66 (7%) |
WBCs (×109/L) | 9 (± 6) | 9 (±5) | 11 (±6) |
Hematocrit (%) | 27 (± 7) | 28 (±8) | 29 (±8) |
Platelets (×109/L) | 114 (±61) | 133 (± 89) | 240 (±119) |
BUN (mg/dL) | 25 (± 17) | 25 (± 18) | 33 (±16) |
Sodium (mmol/L) | 135 (± 5) | 135 (±5) | 136 (±5) |
Creatinine (mg/dL) | 1 (±0.7) | 1.2 (±1.2) | 2.1 (±9.0) |
INR | 1.5 (±0.5) | 1.5 (±0.9) | 1.3 (±0.9) |
Total bilirubin (mg/dL) | 2.7 (± 4.4) | 2.8 (±4.4) | 0.7 (±1.3) |
Albumin (g/dL) | 2.9 (± 0.6) | 2.9 (± 0.7) | n/a |
AST | 72 (±44) | 71 (±44) | 54 (±137) |
ALT | 45 (±33) | 39 (±32) | 32 (±35) |
APRI | 1.8 (± 1.9) | 1.7 (±1.9) | 0.5 (±1.6) |
Lok Index | 0.89 (±0.14) | 0.84 (±0.25) | 0.5 (±0.3) |
AST:ALT ratio | 1.8 (±0.9) | 2.1 (±1.1) | 1.5 (±0.8) |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; APRI, AST to platelet ratio index; BUN, blood urea nitrogen; INR, international normalized ratio; n/a, not applicable; UGIB, upper gastrointestinal bleeding; WBC, white blood cell.